litlas
ログインアカウント作成

Priya Rastogi

2005–2025 年に発表

79
論文数
22,874
被引用数
45
h 指数
75
i10 指数

被引用数

Priya Rastogi の年別被引用数1981 年: 被引用 1 件1982 年: 被引用 2 件1999 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 2 件2006 年: 被引用 13 件2007 年: 被引用 24 件2008 年: 被引用 37 件2009 年: 被引用 32 件2010 年: 被引用 49 件2011 年: 被引用 48 件2012 年: 被引用 52 件2013 年: 被引用 77 件2014 年: 被引用 95 件2015 年: 被引用 160 件2016 年: 被引用 157 件2017 年: 被引用 127 件2018 年: 被引用 131 件2019 年: 被引用 590 件2020 年: 被引用 739 件2021 年: 被引用 882 件2022 年: 被引用 979 件2023 年: 被引用 821 件2024 年: 被引用 1,333 件2025 年: 被引用 709 件2026 年: 被引用 19 件1983〜1998 年は被引用が無いため表示していません2000〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,201 件、この内訳の 22.7%中国: 引用元論文 928 件、この内訳の 9.6%イタリア: 引用元論文 721 件、この内訳の 7.4%ドイツ: 引用元論文 527 件、この内訳の 5.4%イギリス: 引用元論文 486 件、この内訳の 5%スペイン: 引用元論文 418 件、この内訳の 4.3%フランス: 引用元論文 382 件、この内訳の 3.9%カナダ: 引用元論文 375 件、この内訳の 3.9%ベルギー: 引用元論文 287 件、この内訳の 3%スイス: 引用元論文 284 件、この内訳の 2.9%オーストラリア: 引用元論文 249 件、この内訳の 2.6%オランダ: 引用元論文 239 件、この内訳の 2.5%
0%22.7%その他 26.8%

機関

分野

  • Medicine53.8%
  • Biochemistry, Genetics and Molecular Biology40.8%
  • Computer Science1.4%
  • Immunology and Microbiology1.4%
  • Engineering0.7%
  • Materials Science0.5%
  • その他1.4%

トピック

  • Breast Cancer Treatment Studies14.8%
  • HER2/EGFR in Cancer Research10%
  • Advanced Breast Cancer Therapies6.1%
  • Breast Lesions and Carcinomas4.7%
  • Cancer Treatment and Pharmacology3.7%
  • Cancer Immunotherapy and Biomarkers2.9%
  • その他57.8%

共著者

全論文

検索で開く
  1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    著者: Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz - The Lancet 2014 被引用: 4,710

  2. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    著者: Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, William Jacot, Alison Conlin, Claudia Arce-Salinas, Irene Wapnir, Christian Jackisch, Michael P. DiGiovanna, Peter A. Fasching, John Crown, P Wülfing, Zhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H. Lam, David Tesarowski, Melanie C. Smitt, Hannah Douthwaite, Stina Mui Singel, Charles E. Geyer - New England Journal of Medicine 2018 被引用: 2,618

  3. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  4. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

    著者: Stephen Johnston, Masakazu Toi, Joyce O’Shaughnessy, Priya Rastogi, Mario Campone, Patrick Neven, Chiun‐Sheng Huang, Jens Huober, Georgina Garnica Jaliffe, İrfan Çiçin, Sara M. Tolaney, Matthew P. Goetz, Hope S. Rugo, Elżbieta Senkus, Laura Testa, Lucia Del Mastro, Chikako Shimizu, Ran Wei, Ashwin Shahir, Marı́a Jesús Muñoz, Belén San Antonio, Valérie André, Nadia Harbeck, Miguel Martín - The Lancet Oncology 2022 被引用: 566

  5. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

    著者: Stephen R. D. Johnston, Nadia Harbeck, Roberto Hegg, Masakazu Toi, Miguel Martin, Zhi Min Shao, Qing Yuan Zhang, Jorge Luis Martinez Rodriguez, Mario Campone, Erika Hamilton, Joohyuk Sohn, Valentina Guarneri, Morihito Okada, Frances Boyle, Patrick Neven, Javier Cortés, Jens Huober, Andrew Wardley, Sara M. Tolaney, Irfan Cicin, Ian C. Smith, Martin Frenzel, Desirée Headley, Ran Wei, Belen San Antonio, Maarten Hulstijn, Joanne Cox, Joyce O’Shaughnessy, Priya Rastogi - Journal of Clinical Oncology 2020 被引用: 986

  6. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

    著者: Kevin Kalinsky, William E. Barlow, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nancy U. Lin, Edith A. Perez, Lori J. Goldstein, Stephen K.L. Chia, Sukhbinder Dhesy-Thind, Priya Rastogi, Emilio Alba, Suzette Delaloge, Miguel Martin, Catherine M. Kelly, Manuel Ruiz-Borrego, Miguel Gil-Gil, Claudia H. Arce-Salinas, Etienne G.C. Brain, Eun-Sook Lee, Jean-Yves Pierga, Begoña Bermejo, Manuel Ramos-Vazquez, Kyung-Hae Jung, Jean-Marc Ferrero, Anne F. Schott, Steven Shak, Priyanka Sharma, Danika L. Lew, Jieling Miao, Debasish Tripathy, Lajos Pusztai, Gabriel N. Hortobagyi - New England Journal of Medicine 2021 被引用: 832

  7. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross, Priya Rastogi, Karen Cui, Amal Arahmani, Gursel Aktan, Anne Armstrong, Mónica Arnedos, Judith Balmaña, Jonas Bergh, Judith M. Bliss, Suzette Delaloge, Susan M. Domchek, Andrea Eisen, F. Elsafy, L.E. Fein, Anitra Fielding, James M. Ford, Sue Friedman, Karen A. Gelmon, Luca Gianni, Michael Gnant, Simon J. Hollingsworth, Seock‐Ah Im, Agnes Jager, Oskar T. Johannsson, Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  8. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

    著者: Sibylle Loibl, Joyce O’Shaughnessy, Michael Untch, William M. Sikov, Hope S. Rugo, Mark D. McKee, Jens Huober, Mehra Golshan, Gϋnter von Minckwitz, David Maag, Danielle Sullivan, Norman Wolmark, Kristi McIntyre, José Ponce, Otto Metzger, Priya Rastogi, W. Fraser Symmans, Xuan Liu, Charles E. Geyer - The Lancet Oncology 2018 被引用: 771

  9. Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

    著者: Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Judith M. Bliss, Priya Rastogi, Manuela Rabaglio, Som D. Mukherjee, John R. Mackey, Vandana G. Abramson, Conrad D. Oja, Robert Wesolowski, Alastair M. Thompson, Daniel Rea, Paul M. Stos, Lois E. Shepherd, Vuk Stambolic, Wendy R. Parulekar - JAMA 2022 被引用: 223

  10. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+

    著者: Louis Fehrenbacher, Reena S. Cecchini, Charles E. Geyer, Priya Rastogi, Joseph P. Costantino, James N. Atkins, John Crown, Jonathan Polikoff, Jean-François Boileau, Louise Provencher, Christopher Stokoe, Timothy D. Moore, André Robidoux, Patrick J. Flynn, Virginia F. Borges, Kathy S. Albain, Sandra M. Swain, Soonmyung Paik, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2019 被引用: 420

  11. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

    著者: Nadia Harbeck, Priya Rastogi, Miguel Martín, Sara M. Tolaney, Zhimin Shao, Peter A. Fasching, Chiun‐Sheng Huang, Georgina Garnica Jaliffe, A. Tryakin, Matthew P. Goetz, Hope S. Rugo, Elżbieta Senkus, Laura Testa, Mariette Andersson, Kenji Tamura, Lucia Del Mastro, Guenther G. Steger, Hans Kreipe, Roberto Hegg, Joohyuk Sohn, Valentina Guarneri, Javier Cortés, E.P. Hamilton, Valérie André, Ran Wei, Susana Barriga, S. Sherwood, Tammy Forrester, Montserrat Muñoz-Mateu, Ashwin Shahir, Belén San Antonio, Sarah C. Nabinger, Masakazu Toi, Stephen Johnston, Joyce O’Shaughnessy, M.M. Jimenez, Stephen Johnston, F. Boyle, Guenther G. Steger, Patrick Neven, Zefei Jiang, Mario Campone, Jens Huober, Chikako Shimizu, I. Cicin, Andrew Wardley, Sara M. Tolaney, Gonzalo Gómez Abuin, J. J. Zarba, Elgene Lim, P. Sant, Naishun Liao, Bo Christiansen, Natalja Eigėlienė, J. Martin-Babau, Johannes Ettl, D. Mavroudis, Joanne Chiu, Katalin Boér, R. Nagarkar, Shani Paluch–Shimon, Luca Moscetti, Yoshiatsu Sagara, S.-B. Kim, Rui M. B. Maciel, Vivianne C. G. Tjan‐Heijnen, Reuben Broom, Aleksandra Łacko, M. Schenker, Nikita Volkov, Yoon Sim Yap, M.A. Coccia-Portugal, J. Ángel García Sáenz, Anne Andersson, Tai-Jong Chao, Erhan Gökmen, Hakan Harputluoğlu, O. Berzoy, Debra A. Patt, Heather L. McArthur, Helen K. Chew, Pavani Chalasani, Peter A. Kaufman, Karen L. Tedesco, Stephanie L. Graff - Annals of Oncology 2021 被引用: 378

  12. Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

    著者: Priya Rastogi, Joyce O’Shaughnessy, Miguel Martín, Frances Boyle, Javier Cortés, Hope S. Rugo, Matthew P. Goetz, Erika Hamilton, Chiun‐Sheng Huang, Elżbieta Senkus, A. Tryakin, İrfan Çiçin, Laura Testa, Patrick Neven, Jens Huober, Zhimin Shao, Ran Wei, Valérie André, María del Mar Muñoz, Belén San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen Johnston - Journal of Clinical Oncology 2024 被引用: 204

  13. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

    著者: Priya Rastogi, Stewart Anderson, Harry D. Bear, Charles E. Geyer, Morton S. Kahlenberg, André Robidoux, Richard G. Margolese, James L. Hoehn, Victor G. Vogel, Shaker R. Dakhil, Deimante Tamkus, Karen King, Eduardo R. Pajon, Mary Wright, Jean Robert, Soonmyung Paik, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2008 被引用: 1,803

  14. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial

    著者: Charles E. Geyer, William M. Sikov, Jens Huober, Hope S. Rugo, Norman Wolmark, J. O’Shaughnessy, David Maag, Michael Untch, Mehra Golshan, José Ponce, Otto Metzger, Martin Dunbar, W. Fraser Symmans, Priya Rastogi, Joohyuk Sohn, Robyn R. Young, Gail S. Wright, C. Harkness, Kristi McIntyre, Denise A. Yardley, Sibylle Loibl - Annals of Oncology 2022 被引用: 219

  15. Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    著者: Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, George W. Sledge, Charles E. Geyer, Silvana Martino, Priya Rastogi, Julie R. Gralow, Sandra M. Swain, Eric P. Winer, Gerardo Colón‐Otero, Nancy E. Davidson, E. Mamounas, Jo Anne Zujewski, Norman Wolmark - Journal of Clinical Oncology 2014 被引用: 998

  16. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study

    著者: Hope S. Rugo, Joyce O’Shaughnessy, F Boyle, Masakazu Toi, Reuben Broom, Isabel Blancas, M. Gumus, Toshinari Yamashita, Y-H Im, Priya Rastogi, Flora Zagouri, Changhoon Song, Mario Campone, Belén San Antonio, Ashwin Shahir, Maarten Hulstijn, Jacqueline Brown, Annamaria H. Zimmermann, R. Wei, Stephen Johnston, Mattea Reinisch, Sara M. Tolaney - Annals of Oncology 2022 被引用: 128

  17. Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer

    著者: Marion van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc Buyse, Charles E. Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine Piccart, Hervé Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D. Gelber, Coralie Poncet, Pierre Squifflet, Everardo D. Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortés, Valentina Guarneri, Evandro de Azambuja, David Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, on behalf of the CTNeoBC project - Journal of Clinical Oncology 2023 被引用: 96

  18. Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    著者: Edward H. Romond, Jong‐Hyeon Jeong, Priya Rastogi, Sandra M. Swain, Charles E. Geyer, Michael S. Ewer, Vikas Rathi, Louis Fehrenbacher, Adam Brufsky, Catherine A. Azar, Patrick J. Flynn, John L. Zapas, Jonathan Polikoff, Howard M. Gross, David D. Biggs, James N. Atkins, Elizabeth Tan-Chiu, Ping Zheng, Greg Yothers, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2012 被引用: 519

  19. Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer

    著者: Charles E. Geyer, M. Untch, Chiun‐Sheng Huang, Max S. Mano, Eleftherios P. Mamounas, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, Véronique D’Hondt, Alison Conlin, Valentina Guarneri, Irene Wapnir, Christian Jackisch, Claudia Arce-Salinas, Peter A. Fasching, Michael P. DiGiovanna, John Crown, Pia Wuelfing, Zhimin Shao, Elena Rota Caremoli, Hervé Bonnefoi, Bryan T. Hennessy, Ljiljana Stamatović, Hugo Castro‐Salguero, Adam Brufsky, Adam Knott, Asna Siddiqui, Chiara Lambertini, Thomas Boulet, Beatrice Nyawira, Eleonora Restuccia, Sibylle Loibl - New England Journal of Medicine 2025 被引用: 115

  20. Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

    著者: André Robidoux, Gong Tang, Priya Rastogi, Charles E. Geyer, Catherine A. Azar, James N. Atkins, Louis Fehrenbacher, Harry D. Bear, Louis Baez-Diaz, Shakir Sarwar, Richard G. Margolese, William B. Farrar, Adam Brufsky, Henry R. Shibata, Hanna Bandos, Soonmyung Paik, Joseph P. Costantino, Sandra M. Swain, Eleftherios P. Mamounas, Norman Wolmark - The Lancet Oncology 2013 被引用: 386

  21. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, Jong‐Hyeon Jeong, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Thomas E. Seay, James L. Wade, Edward C. McCarron, Soonmyung Paik, Sandra M. Swain, D. Lawrence Wickerham, Norman Wolmark - The Lancet Oncology 2018 被引用: 163

  22. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

    著者: Elizabeth Tan-Chiu, Greg Yothers, Edward H. Romond, Charles E. Geyer, Michael S. Ewer, Deborah Keefe, Richard P. Shannon, Sandra M. Swain, Ann Brown, Louis Fehrenbacher, Victor G. Vogel, Thomas E. Seay, Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark, John Bryant - Journal of Clinical Oncology 2005 被引用: 807

  23. Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

    著者: Otto Metzger, Daniel G. Stover, Sarah Asad, Peter Ansell, Mark A. Watson, Sibylle Loibl, Charles E. Geyer, Junu Bae, Katharine A. Collier, Mathew Cherian, Joyce O’Shaughnessy, Michael Untch, Hope S. Rugo, Jens Huober, Mehra Golshan, William M. Sikov, Gϋnter von Minckwitz, Priya Rastogi, David Maag, Norman Wolmark, Carsten Denkert, W. Fraser Symmans - JAMA Oncology 2021 被引用: 75

  24. Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–Human Epidermal Growth Factor Receptor 2 Therapy

    著者: Pierre Squifflet, Everardo D. Saad, Sibylle Loibl, Marion van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine Piccart, Hervé Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D. Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E. Geyer, Javier Cortés, Valentina Guarneri, Evandro de Azambuja, David Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc Buyse, on behalf of the CTNeoBC Project - Journal of Clinical Oncology 2023 被引用: 55